pSivida

pSivida Corp.
Public company
Traded as NASDAQ: PSDV ASX: PVA FWB: PV3
Industry Pharmaceuticals
Headquarters Watertown, Massachusetts, USA
Number of locations
 2
Products Iluvien
Website www.psivida.com

EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner..In April 2018, pSivida purchased eye products firm Icon Bioscience.[1]

See also

References

  1. ↑ Letter, The Pharma. "BRIEF—pSivida to buy eye products firm Icon Bioscience". www.thepharmaletter.com. Retrieved 2018-06-22.
  • Official website
  • "pSivida (PSDV) Enters Two Funded Evaluation Agreements with Leading Pharma". StreetInsider.com. May 12, 2015. Retrieved May 15, 2015.
  • Lindon, Hal (May 5, 2014). "UPDATE: pSivida Issues Presentation of Preclinical Data Showing Sustained Release of Avastin Using Tethadur". Benzinga. Retrieved May 15, 2015. pSivida's Dinesh K. Nadarassan presented a poster entitled “Sustained Release of Bevacizumab (Avastin) from BioSilicon”


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.